Germacranolide sesquiterpenes from Carpesium cernuum and their anti-leukemia activity
Chen Yan,Qun Long,Yun-Dong Zhang,Gajendran Babu,Madhu Varier Krishnapriya,Jian-Fei Qiu,Jing-Rui Song,Qing Rao,Ping Yi,Mao Sun,Yan-Mei Li,Chen YAN,Qun LONG,Yun-Dong ZHANG,Gajendran BABU,Madhu Varier KRISHNAPRIYA,Jian-Fei QIU,Jing-Rui SONG,Qing RAO,Ping YI,Mao SUN,Yan-Mei LI
DOI: https://doi.org/10.1016/s1875-5364(21)60052-3
IF: 3.887
2021-07-01
Chinese Journal of Natural Medicines
Abstract:In this study, three new germacranolide sesquiterpenes (<strong>1–3</strong>), together with six related known analogues (<strong>4–9</strong>) were isolated from the whole plant of <em>Carpesium cernuum</em>. Their structures were established by a combination of extensive NMR spectroscopic analysis, HR-ESIMS data, and ECD calculations. The anti-leukemia activities of all compounds towards three cell lines (HEL, KG-1a, and K562) were evaluated in <em>vitro</em>. Compounds <strong>1–3</strong> exhibited moderate cytotoxicity with IC<sub>50</sub> values ranging from 1.59 to 5.47 μmol·L<sup>−1</sup>. Mechanistic studies indicated that <strong>2</strong> induced apoptosis by decreasing anti-apoptotic protein Bcl-2 and activating the caspase family in K562 cells. These results suggest that compound <strong>2</strong> is a potential anti-leukemia agent.
pharmacology & pharmacy,integrative & complementary medicine